Literature DB >> 32859634

Cytogenetic and Molecular Study of an Adult Sclerosing Rhabdomyosarcoma of the Extremity: MYOD1-mutation and Clonal Evolution.

Ludmila Gorunova1, Bodil Bjerkehagen2,3,4, Francesca Micci5, Sverre Heim5,3, Ioannis Panagopoulos5.   

Abstract

BACKGROUND: Spindle cell/sclerosing rhabdomyosarcoma is a genomically heterogeneous, uncommon subtype of rhabdomyosarcoma, particularly rare in adults. Its MYOD1-mutant variant is aggressive irrespective of age. Cytogenetic data on spindle cell/sclerosing rhabdomyosarcoma are sparse and disparate.
MATERIALS AND METHODS: Cytogenetic and molecular analyses were performed on an adult sclerosing rhabdomyosarcoma.
RESULTS: The karyotype of the sclerosing rhabdomyosarcoma displayed clonal evolution corresponding to two hyperdiploid clones: 48,XY,+i(19)(p10),+22/48,idem,der(9)t(2;9)(q21~22;p21). The changes were gain of chromosome 19 with the overrepresentation of 19p arm, gain of chromosome 22, gain of the 2q arm, and loss of 9p21. Mutation analysis revealed a homozygous c.T365G (p.L122R) mutation of the MYOD1 gene, but none of PIK3CA.
CONCLUSION: To our knowledge, this is the first adult MYOD1-mutant sclerosing rhabdomyosarcoma studied cytogenetically. The only other reported sclerosing rhabdomyosarcoma with MYOD1 mutation and abnormal karyotype was pediatric. Since these tumors are highly aggressive, further studies unravelling their cytogenetic and molecular characteristics are warranted. Copyright
© 2020, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Adult sclerosing rhabdomyosarcoma; MYOD1-mutation; chromosome aberrations; clonal evolution

Mesh:

Substances:

Year:  2020        PMID: 32859634      PMCID: PMC7472446          DOI: 10.21873/cgp.20212

Source DB:  PubMed          Journal:  Cancer Genomics Proteomics        ISSN: 1109-6535            Impact factor:   4.069


  18 in total

1.  Cytogenetic study of a spindle-cell rhabdomyosarcoma of the parotid gland.

Authors:  R Gil-Benso; C Carda-Batalla; S Navarro-Fos; A Pellín-Perez; A Llombart-Bosch
Journal:  Cancer Genet Cytogenet       Date:  1999-03

2.  Spindle-cell rhabdomyosarcoma with 2q36 approximately q37 involvement.

Authors:  Maria Debiec-Rychter; Anne Hagemeijer; Raf Sciot
Journal:  Cancer Genet Cytogenet       Date:  2003-01-01

3.  Genetic heterogeneity in rhabdomyosarcoma revealed by SNP array analysis.

Authors:  Charles Walther; Markus Mayrhofer; Jenny Nilsson; Jakob Hofvander; Tord Jonson; Nils Mandahl; Ingrid Øra; David Gisselsson; Fredrik Mertens
Journal:  Genes Chromosomes Cancer       Date:  2015-10-20       Impact factor: 5.006

4.  A recurrent neomorphic mutation in MYOD1 defines a clinically aggressive subset of embryonal rhabdomyosarcoma associated with PI3K-AKT pathway mutations.

Authors:  Shinji Kohsaka; Neerav Shukla; Nabahet Ameur; Tatsuo Ito; Charlotte K Y Ng; Lu Wang; Diana Lim; Angela Marchetti; Agnes Viale; Mono Pirun; Nicholas D Socci; Li-Xuan Qin; Raf Sciot; Julia Bridge; Samuel Singer; Paul Meyers; Leonard H Wexler; Frederic G Barr; Snjezana Dogan; Jonathan A Fletcher; Jorge S Reis-Filho; Marc Ladanyi
Journal:  Nat Genet       Date:  2014-05-04       Impact factor: 38.330

Review 5.  The current landscape of rhabdomyosarcomas: an update.

Authors:  Julia Leiner; François Le Loarer
Journal:  Virchows Arch       Date:  2019-11-06       Impact factor: 4.064

6.  Pediatric sclerosing rhabdomyosarcoma.

Authors:  Eduardo Zambrano; Antonio R Pérez-Atayde; William Ahrens; Miguel Reyes-Múgica
Journal:  Int J Surg Pathol       Date:  2006-07       Impact factor: 1.271

7.  Comprehensive genomic analysis of rhabdomyosarcoma reveals a landscape of alterations affecting a common genetic axis in fusion-positive and fusion-negative tumors.

Authors:  Jack F Shern; Li Chen; Juliann Chmielecki; Jun S Wei; Rajesh Patidar; Mara Rosenberg; Lauren Ambrogio; Daniel Auclair; Jianjun Wang; Young K Song; Catherine Tolman; Laura Hurd; Hongling Liao; Shile Zhang; Dominik Bogen; Andrew S Brohl; Sivasish Sindiri; Daniel Catchpoole; Thomas Badgett; Gad Getz; Jaume Mora; James R Anderson; Stephen X Skapek; Frederic G Barr; Matthew Meyerson; Douglas S Hawkins; Javed Khan
Journal:  Cancer Discov       Date:  2014-01-23       Impact factor: 39.397

Review 8.  Spindle cell rhabdomyosarcoma of the neck with t(6;8) translocation: report of a case and literature review.

Authors:  Mark J Mentrikoski; Wendy Golden; T David Bourne; Robin Legallo
Journal:  Pediatr Dev Pathol       Date:  2012-10-31

9.  Recurrent NCOA2 gene rearrangements in congenital/infantile spindle cell rhabdomyosarcoma.

Authors:  Juan Miguel Mosquera; Andrea Sboner; Lei Zhang; Naoki Kitabayashi; Chun-Liang Chen; Yun Shao Sung; Leonard H Wexler; Michael P LaQuaglia; Morris Edelman; Chandrika Sreekantaiah; Mark A Rubin; Cristina R Antonescu
Journal:  Genes Chromosomes Cancer       Date:  2013-03-05       Impact factor: 5.006

10.  MYOD1-mutant spindle cell and sclerosing rhabdomyosarcoma: an aggressive subtype irrespective of age. A reappraisal for molecular classification and risk stratification.

Authors:  Narasimhan P Agaram; Michael P LaQuaglia; Rita Alaggio; Lei Zhang; Yumi Fujisawa; Marc Ladanyi; Leonard H Wexler; Cristina R Antonescu
Journal:  Mod Pathol       Date:  2018-09-04       Impact factor: 7.842

View more
  1 in total

1.  Cytogenetic and molecular analyses of 291 gastrointestinal stromal tumors: site-specific cytogenetic evolution as evidence of pathogenetic heterogeneity.

Authors:  Ludmila Gorunova; Kjetil Boye; Ioannis Panagopoulos; Jeanne-Marie Berner; Bodil Bjerkehagen; Ivar Hompland; Ingvild Lobmaier; Toto Hølmebakk; Tarjei S Hveem; Sverre Heim; Francesca Micci
Journal:  Oncotarget       Date:  2022-03-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.